Lv0
0 积分 2025-07-08 加入
Pharmacokinetics, metabolism and distribution of PEGs and PEGylated proteins: quo vadis?
1个月前
已完结
Poly(ethylene glycol) immunogenicity in tissue engineering
1个月前
已完结
Functional diversification of cell signaling by GPCR localization
2个月前
已完结
Trends in GPCR drug discovery: new agents, targets and indications
2个月前
已完结
GPCR drug discovery: new agents, targets and indications
2个月前
已完结
IL-2Rα-biased agonist enhances antitumor immunity by invigorating tumor-infiltrating CD25+CD8+ T cells
3个月前
已完结
Structure of the Prefusion Form of the Vesicular Stomatitis Virus Glycoprotein G
4个月前
已完结
Safety and efficacy of once-weekly efruxifermin versus placebo in non-alcoholic steatohepatitis (HARMONY): a multicentre, randomised, double-blind, placebo-controlled, phase 2b trial
7个月前
已完结
Efruxifermin in non-alcoholic steatohepatitis: a randomized, double-blind, placebo-controlled, phase 2a trial
7个月前
已完结
BL-B01D1, a first-in-class EGFR–HER3 bispecific antibody–drug conjugate, in patients with locally advanced or metastatic solid tumours: a first-in-human, open-label, multicentre, phase 1 study
8个月前
已完结
皖公网安备34019202002308
